Nunzia Pharmaceutical Company
NUNZ
$0.00
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 96.97M | 96.78M | 96.77M | 78.06M | 80.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 96.97M | 96.78M | 96.77M | 78.06M | 80.80K |
| Operating Income | -96.97M | -96.78M | -96.77M | -78.06M | -80.80K |
| Income Before Tax | -96.99M | -96.78M | -96.77M | -78.06M | -101.06M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -96.99 | -96.78 | -96.77 | -78.06 | -101.06 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -96.99M | -96.78M | -96.77M | -78.06M | -101.06M |
| EBIT | -96.97M | -96.78M | -96.77M | -78.06M | -80.80K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.27 | -0.27 | -0.27 | -0.22 | -0.35 |
| Normalized Basic EPS | -0.17 | -0.17 | -0.17 | -0.14 | -0.22 |
| EPS Diluted | -0.27 | -0.27 | -0.27 | -0.22 | -0.35 |
| Normalized Diluted EPS | -0.17 | -0.17 | -0.17 | -0.14 | -0.22 |
| Average Basic Shares Outstanding | 1.65B | 1.51B | 1.36B | 1.22B | 1.15B |
| Average Diluted Shares Outstanding | 1.65B | 1.51B | 1.36B | 1.22B | 1.15B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |